Your browser doesn't support javascript.
loading
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Burch, Henry B; Perros, Petros; Bednarczuk, Tomasz; Cooper, David S; Dolman, Peter J; Leung, Angela M; Mombaerts, Ilse; Salvi, Mario; Stan, Marius N.
Afiliação
  • Burch HB; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Perros P; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Bednarczuk T; Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Cooper DS; Department of Endocrinology, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Dolman PJ; Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
  • Leung AM; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mombaerts I; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada.
  • Salvi M; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
  • Stan MN; Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
Thyroid ; 32(12): 1439-1470, 2022 12.
Article em En | MEDLINE | ID: mdl-36480280
ABSTRACT
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oftalmopatia de Graves / Hipertireoidismo Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oftalmopatia de Graves / Hipertireoidismo Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos